My Personal CFO LLC Sells 60 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

My Personal CFO LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,822 shares of the healthcare conglomerate’s stock after selling 60 shares during the period. My Personal CFO LLC’s holdings in UnitedHealth Group were worth $1,065,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Delta Financial Group Inc. raised its position in shares of UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after buying an additional 17 shares during the period. Signature Resources Capital Management LLC grew its holdings in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC lifted its position in UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after buying an additional 18 shares during the last quarter. GoalVest Advisory LLC increased its position in shares of UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after acquiring an additional 18 shares during the last quarter. Finally, Fiduciary Group LLC boosted its position in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 0.3 %

UNH stock opened at $569.98 on Wednesday. The company has a fifty day moving average price of $584.46 and a 200 day moving average price of $536.30. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company has a market cap of $526.33 billion, a price-to-earnings ratio of 37.13, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the business earned $6.56 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on UNH. Cantor Fitzgerald lifted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Argus boosted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, Wells Fargo & Company upped their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.